{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:41:03Z","timestamp":1793245263482,"version":"4.5.0"},"reference-count":235,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Bone is a dynamic organ maintained by tightly regulated mechanisms. With old age, bone homeostasis, which is maintained by an intricate balance between bone formation and bone resorption, undergoes deregulation. Oxidative stress-induced DNA damage, cellular apoptosis, and cellular senescence are all responsible for this tissue dysfunction and the imbalance in the bone homeostasis. These cellular mechanisms have become a target for therapeutics to treat age-related osteoporosis. Genetic mouse models have shown the importance of senescent cell clearance in alleviating age-related osteoporosis. Furthermore, we and others have shown that targeting cellular senescence pharmacologically was an effective tool to alleviate age- and radiation-induced osteoporosis. Senescent cells also have an altered secretome known as the senescence associated secretory phenotype (SASP), which may have autocrine, paracrine, or endocrine function. The current review discusses the current and potential pathways which lead to a senescence profile in an aged skeleton and how bone homeostasis is affected during age-related osteoporosis. The review has also discussed existing therapeutics for the treatment of osteoporosis and rationalizes for novel therapeutic options based on cellular senescence and the SASP as an underlying pathogenesis of an aging bone.<\/jats:p>","DOI":"10.3390\/ijms22073553","type":"journal-article","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T16:01:57Z","timestamp":1617033717000},"page":"3553","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":262,"title":["Skeletal Aging and Osteoporosis: Mechanisms and Therapeutics"],"prefix":"10.3390","volume":"22","author":[{"given":"Abhishek","family":"Chandra","sequence":"first","affiliation":[{"name":"Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN 55902, USA"},{"name":"Department of Internal Medicine, Division of Geriatric Medicine and Gerontology, Mayo Clinic, Rochester, MN 55902, USA"},{"name":"Robert and Arlene Kogod Aging Center, Mayo Clinic, Rochester, MN 55902, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotika","family":"Rajawat","sequence":"additional","affiliation":[{"name":"Department of Zoology, University of Lucknow, University Rd, Babuganj, Hasanganj, Lucknow, Uttar Pradesh 226007, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,3,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5152\/eurjrheum.2016.048","article-title":"An overview and management of osteoporosis","volume":"4","author":"Sozen","year":"2017","journal-title":"Eur. J. Rheumatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1210\/er.2009-0024","article-title":"From estrogen-centric to aging and oxidative stress: A revised perspective of the pathogenesis of osteoporosis","volume":"31","author":"Manolagas","year":"2010","journal-title":"Endocr. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1359\/jbmr.1998.13.5.763","article-title":"A unitary model for involutional osteoporosis: Estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men","volume":"13","author":"Riggs","year":"1998","journal-title":"J. Bone Miner. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/jbmr.3729","article-title":"Independent Roles of Estrogen Deficiency and Cellular Senescence in the Pathogenesis of Osteoporosis: Evidence in Young Adult Mice and Older Humans","volume":"34","author":"Farr","year":"2019","journal-title":"J. Bone Miner. Res."},{"key":"ref_5","unstructured":"Marcus, R., Feldman, D., Dempster, D.W., Luckey, M., and Cauley, J.A. (2013). Chapter 46\u2013Estrogen Deficiency, Postmenopausal Osteoporosis, and Age-Related Bone Loss. Osteoporosis, Academic Press. [4st ed.]."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1210\/endo.139.3.5837","article-title":"Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG\/OCIF inhibits osteoclastogenesis in vitro","volume":"139","author":"Yasuda","year":"1998","journal-title":"Endocrinology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/nm.2448","article-title":"Matrix-embedded cells control osteoclast formation","volume":"17","author":"Xiong","year":"2011","journal-title":"Nat. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1073\/pnas.97.4.1566","article-title":"RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism","volume":"97","author":"Li","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/mpo.10334","article-title":"Biology of the basic multicellular unit and the pathophysiology of osteoporosis","volume":"41","author":"Jilka","year":"2003","journal-title":"Med. Pediatr. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1089\/ten.tea.2017.0026","article-title":"Extracellular Matrices for Bone Regeneration: A Literature Review","volume":"23","author":"Mansour","year":"2017","journal-title":"Tissue Eng. Part. A"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"6815","DOI":"10.1016\/S0021-9258(17)37449-5","article-title":"Characterization and autoregulation of latent transforming growth factor beta (TGF beta) complexes in osteoblast-like cell lines. Production of a latent complex lacking the latent TGF beta-binding protein","volume":"269","author":"Dallas","year":"1994","journal-title":"J. Biol. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nm.1979","article-title":"TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation","volume":"15","author":"Tang","year":"2009","journal-title":"Nat. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1073\/pnas.78.5.3204","article-title":"Parathyroid hormone stimulates bone formation and resorption in organ culture: Evidence for a coupling mechanism","volume":"78","author":"Howard","year":"1981","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/nm.2793","article-title":"Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells","volume":"18","author":"Xian","year":"2012","journal-title":"Nat. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/nm.2452","article-title":"Evidence for osteocyte regulation of bone homeostasis through RANKL expression","volume":"17","author":"Nakashima","year":"2011","journal-title":"Nat. Med."},{"key":"ref_19","first-page":"115","article-title":"Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis","volume":"21","author":"Manolagas","year":"2000","journal-title":"Endocr. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.bone.2015.02.016","article-title":"Quantifying the osteocyte network in the human skeleton","volume":"75","author":"Buenzli","year":"2015","journal-title":"Bone"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Kim, J.M., Lin, C., Stavre, Z., Greenblatt, M.B., and Shim, J.H. (2020). Osteoblast-Osteoclast Communication and Bone Homeostasis. Cells, 9.","DOI":"10.3390\/cells9092073"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S8756-3282(00)00236-2","article-title":"Decline in osteocyte lacunar density in human cortical bone is associated with accumulation of microcracks with age","volume":"26","author":"Vashishth","year":"2000","journal-title":"Bone"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1474-9726.2010.00616.x","article-title":"Decreased oxidative stress and greater bone anabolism in the aged, when compared to the young, murine skeleton with parathyroid hormone administration","volume":"9","author":"Jilka","year":"2010","journal-title":"Aging Cell"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bone.2005.12.082","article-title":"Inhibition of osteoblast differentiation but not adipocyte differentiation of mesenchymal stem cells by sera obtained from aged females","volume":"39","author":"Abdallah","year":"2006","journal-title":"Bone"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/jbmr.2892","article-title":"Identification of Senescent Cells in the Bone Microenvironment","volume":"31","author":"Farr","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1474-9726.2011.00669.x","article-title":"Senescence-associated intrinsic mechanisms of osteoblast dysfunctions","volume":"10","author":"Kassem","year":"2011","journal-title":"Aging Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bone.2016.01.014","article-title":"Aging alters bone-fat reciprocity by shifting in vivo mesenchymal precursor cell fate towards an adipogenic lineage","volume":"85","author":"Singh","year":"2016","journal-title":"Bone"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"bvaa200","DOI":"10.1210\/jendso\/bvaa200","article-title":"Gene Testing in Everyday Clinical Use: Lessons from the Bone Clinic","volume":"5","author":"Duncan","year":"2021","journal-title":"J. Endocr. Soc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/jbmr.344","article-title":"Trabecular bone microstructure and local gene expression in iliac crest biopsies of men with idiopathic osteoporosis","volume":"26","author":"Patsch","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Farr, J.N., Roforth, M.M., Fujita, K., Nicks, K.M., Cunningham, J.M., Atkinson, E.J., Therneau, T.M., McCready, L.K., Peterson, J.M., and Drake, M.T. (2015). Effects of Age and Estrogen on Skeletal Gene Expression in Humans as Assessed by RNA Sequencing. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0138347"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12020-017-1429-8","article-title":"Calcium-sensing receptor polymorphisms increase the risk of osteoporosis in ageing males","volume":"61","author":"Rocca","year":"2018","journal-title":"Endocrine"},{"key":"ref_32","first-page":"144","article-title":"Collagen Type I alpha1 (COL1A1) Gene Polymorphism and Bone Mineral Density in Postmenopausal Kazakh Women","volume":"3","author":"Aitkulova","year":"2014","journal-title":"Cent. Asian J. Glob. Health"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00198-006-0225-8","article-title":"COL1A1, ESR1, VDR and TGFB1 polymorphisms and haplotypes in relation to BMD in Spanish postmenopausal women","volume":"18","author":"Bustamante","year":"2007","journal-title":"Osteoporos. Int."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s11357-011-9363-9","article-title":"JAG1 and COL1A1 polymorphisms and haplotypes in relation to bone mineral density variations in postmenopausal Mexican-Mestizo Women","volume":"35","author":"Espinosa","year":"2013","journal-title":"Age"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"eaau7137","DOI":"10.1126\/scitranslmed.aau7137","article-title":"Wnt1 is an Lrp5-independent bone-anabolic Wnt ligand","volume":"10","author":"Luther","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0014-4827(61)90192-6","article-title":"The serial cultivation of human diploid cell strains","volume":"25","author":"Hayflick","year":"1961","journal-title":"Exp. Cell Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0092-8674(00)81902-9","article-title":"Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a","volume":"88","author":"Serrano","year":"1997","journal-title":"Cell"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"34118","DOI":"10.18632\/oncotarget.5947","article-title":"Aging with ING: A comparative study of different forms of stress induced premature senescence","volume":"6","author":"Rajarajacholan","year":"2015","journal-title":"Oncotarget"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1186\/s12864-016-3352-4","article-title":"Pathways of aging: Comparative analysis of gene signatures in replicative senescence and stress induced premature senescence","volume":"17","author":"Kural","year":"2016","journal-title":"BMC Genom."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1152\/physrev.1993.73.3.617","article-title":"Replicative senescence of human fibroblast-like cells in culture","volume":"73","author":"Cristofalo","year":"1993","journal-title":"Physiol. Rev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0092-8674(03)00401-X","article-title":"Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence","volume":"113","author":"Narita","year":"2003","journal-title":"Cell"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","article-title":"WAF1, a potential mediator of p53 tumor suppression","volume":"75","author":"Tokino","year":"1993","journal-title":"Cell"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1128\/MCB.19.3.2109","article-title":"Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts","volume":"19","author":"Stein","year":"1999","journal-title":"Mol. Cell Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/366704a0","article-title":"A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D\/CDK4","volume":"366","author":"Serrano","year":"1993","journal-title":"Nature"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"13742","DOI":"10.1073\/pnas.93.24.13742","article-title":"Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts","volume":"93","author":"Alcorta","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nature16932","article-title":"Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan","volume":"530","author":"Baker","year":"2016","journal-title":"Nature"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature10600","article-title":"Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders","volume":"479","author":"Baker","year":"2011","journal-title":"Nature"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/acel.12445","article-title":"Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors","volume":"15","author":"Zhu","year":"2016","journal-title":"Aging Cell"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMra0804615","article-title":"DNA damage, aging, and cancer","volume":"361","author":"Hoeijmakers","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.1070174","article-title":"Premature aging in mice deficient in DNA repair and transcription","volume":"296","author":"Andressoo","year":"2002","journal-title":"Science"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1093\/hmg\/ddl116","article-title":"Atm-deficient mice: An osteoporosis model with defective osteoblast differentiation and increased osteoclastogenesis","volume":"15","author":"Rasheed","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.stem.2007.03.002","article-title":"Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss","volume":"1","author":"Ruzankina","year":"2007","journal-title":"Cell Stem Cell"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/jbmr.1851","article-title":"DNA damage drives accelerated bone aging via an NF-kappaB-dependent mechanism","volume":"28","author":"Chen","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/stem.2255","article-title":"Zoledronate Attenuates Accumulation of DNA Damage in Mesenchymal Stem Cells and Protects Their Function","volume":"34","author":"Misra","year":"2016","journal-title":"Stem Cells"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1074\/jbc.M114.608158","article-title":"PTH1-34 blocks radiation-induced osteoblast apoptosis by enhancing DNA repair through canonical Wnt pathway","volume":"290","author":"Chandra","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/jbmr.2996","article-title":"Suppression of Sclerostin Alleviates Radiation-Induced Bone Loss by Protecting Bone-Forming Cells and Their Progenitors Through Distinct Mechanisms","volume":"32","author":"Chandra","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1096\/fj.201700375R","article-title":"Proteasome inhibitor bortezomib is a novel therapeutic agent for focal radiation-induced osteoporosis","volume":"32","author":"Chandra","year":"2018","journal-title":"FASEB J."},{"key":"ref_58","first-page":"1496","article-title":"Principle of marginotomy in template synthesis of polynucleotides","volume":"201","author":"Olovnikov","year":"1971","journal-title":"Dokl. Akad. Nauk SSSR"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/newbio239197a0","article-title":"Origin of concatemeric T7 DNA","volume":"239","author":"Watson","year":"1972","journal-title":"Nat. New Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nature02118","article-title":"A DNA damage checkpoint response in telomere-initiated senescence","volume":"426","author":"Reaper","year":"2003","journal-title":"Nature"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/jbmr.3978","article-title":"Targeted Reduction of Senescent Cell Burden Alleviates Focal Radiotherapy-Related Bone Loss","volume":"35","author":"Chandra","year":"2020","journal-title":"J. Bone Miner. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1634\/stemcells.22-5-675","article-title":"Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion","volume":"22","author":"Baxter","year":"2004","journal-title":"Stem Cells"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/humu.9435","article-title":"Werner syndrome and mutations of the WRN and LMNA genes in France","volume":"27","author":"Uhrhammer","year":"2006","journal-title":"Hum. Mutat."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1474-9726.2007.00350.x","article-title":"Defects in telomere maintenance molecules impair osteoblast differentiation and promote osteoporosis","volume":"7","author":"Pignolo","year":"2008","journal-title":"Aging Cell"},{"key":"ref_65","first-page":"583","article-title":"Mouse models of telomere dysfunction phenocopy skeletal changes found in human age-related osteoporosis","volume":"7","author":"Brennan","year":"2014","journal-title":"Dis. Model. Mech."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"8073","DOI":"10.1073\/pnas.0800042105","article-title":"Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita","volume":"105","author":"Vulliamy","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1002\/jbmr.3148","article-title":"Epigenome-wide Association of DNA Methylation in Whole Blood With Bone Mineral Density","volume":"32","author":"Morris","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/jbmr.3298","article-title":"Primary Osteoporosis Is Not Reflected by Disease-Specific DNA Methylation or Accelerated Epigenetic Age in Blood","volume":"33","author":"Eipel","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Jintaridth, P., Tungtrongchitr, R., Preutthipan, S., and Mutirangura, A. (2013). Hypomethylation of Alu elements in post-menopausal women with osteoporosis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0070386"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1080\/15592294.2017.1345832","article-title":"Distinct DNA methylation profiles in bone and blood of osteoporotic and healthy postmenopausal women","volume":"12","author":"Reppe","year":"2017","journal-title":"Epigenetics"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1210\/me.2012-1302","article-title":"HDAC7 inhibits osteoclastogenesis by reversing RANKL-triggered beta-catenin switch","volume":"27","author":"Jin","year":"2013","journal-title":"Mol. Endocrinol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"24069","DOI":"10.1074\/jbc.M114.561803","article-title":"Sirtuin1 (Sirt1) promotes cortical bone formation by preventing beta-catenin sequestration by FoxO transcription factors in osteoblast progenitors","volume":"289","author":"Iyer","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1359\/JBMR.050813","article-title":"Histone deacetylase inhibitors promote osteoblast maturation","volume":"20","author":"Schroeder","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"12894","DOI":"10.1074\/jbc.RA118.002983","article-title":"Enhancer of zeste homolog 2 (Ezh2) controls bone formation and cell cycle progression during osteogenesis in mice","volume":"293","author":"Dudakovic","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"24594","DOI":"10.1074\/jbc.M116.740571","article-title":"Enhancer of Zeste Homolog 2 Inhibition Stimulates Bone Formation and Mitigates Bone Loss Caused by Ovariectomy in Skeletally Mature Mice","volume":"291","author":"Dudakovic","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"7877","DOI":"10.1074\/jbc.RA119.011685","article-title":"Inhibition of the epigenetic suppressor EZH2 primes osteogenic differentiation mediated by BMP2","volume":"295","author":"Dudakovic","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1089\/scd.2015.0384","article-title":"Identification of Novel EZH2 Targets Regulating Osteogenic Differentiation in Mesenchymal Stem Cells","volume":"25","author":"Hemming","year":"2016","journal-title":"Stem Cells Dev."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/art.37753","article-title":"Genome-wide profiling of bone reveals differentially methylated regions in osteoporosis and osteoarthritis","volume":"65","author":"Fernandez","year":"2013","journal-title":"Arthritis Rheum."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"eaaz1410","DOI":"10.1126\/sciadv.aaz1410","article-title":"Histone demethylase LSD1 is critical for endochondral ossification during bone fracture healing","volume":"6","author":"Sun","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41413-018-0015-x","article-title":"Histone demethylase LSD1 regulates bone mass by controlling WNT7B and BMP2 signaling in osteoblasts","volume":"6","author":"Sun","year":"2018","journal-title":"Bone Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.stem.2012.04.009","article-title":"Histone demethylases KDM4B and KDM6B promotes osteogenic differentiation of human MSCs","volume":"11","author":"Ye","year":"2012","journal-title":"Cell Stem Cell"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"16215","DOI":"10.1038\/s41598-018-34255-4","article-title":"Epigenetic enzymes influenced by oxidative stress and hypoxia mimetic in osteoblasts are differentially expressed in patients with osteoporosis and osteoarthritis","volume":"8","author":"Vrtacnik","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1002\/stem.2424","article-title":"Histone H3K9 Acetyltransferase PCAF Is Essential for Osteogenic Differentiation Through Bone Morphogenetic Protein Signaling and May Be Involved in Osteoporosis","volume":"34","author":"Zhang","year":"2016","journal-title":"Stem Cells"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00508-016-1141-3","article-title":"MiR-148a the epigenetic regulator of bone homeostasis is increased in plasma of osteoporotic postmenopausal women","volume":"128","author":"Bedene","year":"2016","journal-title":"Wien. Klin. Wochenschr."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1089\/scd.2016.0133","article-title":"miRNAs Related to Skeletal Diseases","volume":"25","author":"Seeliger","year":"2016","journal-title":"Stem Cells Dev."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/stem.2211","article-title":"Abrogation of Age-Induced MicroRNA-195 Rejuvenates the Senescent Mesenchymal Stem Cells by Reactivating Telomerase","volume":"34","author":"Okada","year":"2016","journal-title":"Stem Cells"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"7","DOI":"10.18632\/oncotarget.6589","article-title":"miR-195 in human primary mesenchymal stromal\/stem cells regulates proliferation, osteogenesis and paracrine effect on angiogenesis","volume":"7","author":"Almeida","year":"2016","journal-title":"Oncotarget"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jbmr.3586","article-title":"miR-219a-5p Regulates Rorbeta During Osteoblast Differentiation and in Age-related Bone Loss","volume":"34","author":"Farr","year":"2019","journal-title":"J. Bone Miner. Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1002\/jbmr.1604","article-title":"miR-182 is a negative regulator of osteoblast proliferation, differentiation, and skeletogenesis through targeting FoxO1","volume":"27","author":"Kim","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.bbrc.2019.06.083","article-title":"MiRNA-19a-3p alleviates the progression of osteoporosis by targeting HDAC4 to promote the osteogenic differentiation of hMSCs","volume":"516","author":"Chen","year":"2019","journal-title":"BioChem. Biophys Res. Commun."},{"key":"ref_91","first-page":"526","article-title":"LncRNA TERC alleviates the progression of osteoporosis by absorbing miRNA-217 to upregulate RUNX2","volume":"24","author":"Gao","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"101479","DOI":"10.1016\/j.mcp.2019.101479","article-title":"MiRNA-483-5p is involved in the pathogenesis of osteoporosis by promoting osteoclast differentiation","volume":"49","author":"Li","year":"2020","journal-title":"Mol. Cell Probes"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/abbs\/gmy006","article-title":"MiRNA-133a is involved in the regulation of postmenopausal osteoporosis through promoting osteoclast differentiation","volume":"50","author":"Li","year":"2018","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.bbrc.2020.02.058","article-title":"Keratinocytes-derived exosomal miRNA regulates osteoclast differentiation in middle ear cholesteatoma","volume":"525","author":"Gong","year":"2020","journal-title":"BioChem. Biophys. Res. Commun."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Guo, K., Zhang, D., Wu, H., Zhu, Q., Yang, C., and Zhu, J. (2018). MiRNA-199a-5p positively regulated RANKL-induced osteoclast differentiation by target Mafb protein. J. Cell BioChem.","DOI":"10.1002\/jcb.27968"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1210\/jc.2016-2365","article-title":"Circulating microRNA Signatures in Patients With Idiopathic and Postmenopausal Osteoporosis and Fragility Fractures","volume":"101","author":"Kocijan","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1038\/s41598-018-22844-2","article-title":"Bone-related Circulating MicroRNAs miR-29b-3p, miR-550a-3p, and miR-324-3p and their Association to Bone Microstructure and Histomorphometry","volume":"8","author":"Feichtinger","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"115779","DOI":"10.1016\/j.bone.2020.115779","article-title":"Inhibition of miR-29-3p isoforms via tough decoy suppresses osteoblast function in homeostasis but promotes intermittent parathyroid hormone-induced bone anabolism","volume":"143","author":"Hrdlicka","year":"2021","journal-title":"Bone"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1261\/rna.049148.114","article-title":"Global miRNA expression and correlation with mRNA levels in primary human bone cells","volume":"21","author":"Laxman","year":"2015","journal-title":"RNA"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.mce.2016.04.014","article-title":"miRNA-29b improves bone healing in mouse fracture model","volume":"430","author":"Lee","year":"2016","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nature16187","article-title":"Autophagy maintains stemness by preventing senescence","volume":"529","author":"Perdiguero","year":"2016","journal-title":"Nature"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1080\/15548627.2018.1483807","article-title":"Defective autophagy in osteoblasts induces endoplasmic reticulum stress and causes remarkable bone loss","volume":"14","author":"Li","year":"2018","journal-title":"Autophagy"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e12709","DOI":"10.1111\/acel.12709","article-title":"Autophagy controls mesenchymal stem cell properties and senescence during bone aging","volume":"17","author":"Ma","year":"2018","journal-title":"Aging Cell"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1474-9726.2008.00425.x","article-title":"Partial proteasome inhibition in human fibroblasts triggers accelerated M1 senescence or M2 crisis depending on p53 and Rb status","volume":"7","author":"Chondrogianni","year":"2008","journal-title":"Aging Cell"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"196249","DOI":"10.1155\/2014\/196249","article-title":"Hypoxia enhances the senescence effect of bortezomib--the proteasome inhibitor--on human skin fibroblasts","volume":"2014","author":"Kretowski","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/gerona\/63.2.200","article-title":"Effects of ubiquitin-proteasome system deregulation on the vascular senescence and atherosclerosis process in elderly patients","volume":"63","author":"Marfella","year":"2008","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1172\/JCI16198","article-title":"Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro","volume":"111","author":"Garrett","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1196\/annals.1402.077","article-title":"Proteasome inhibitors stimulate both bone formation and hair growth by similar mechanisms","volume":"1117","author":"Mundy","year":"2007","journal-title":"Ann. N. Y Acad. Sci."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1091\/mbc.e12-03-0192","article-title":"Quiescent fibroblasts are protected from proteasome inhibition-mediated toxicity","volume":"23","author":"Raitman","year":"2012","journal-title":"Mol. Biol. Cell"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1006\/excr.1995.1305","article-title":"Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: A model for senescence?","volume":"220","author":"Saretzki","year":"1995","journal-title":"Exp. Cell Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1101\/gad.331272.119","article-title":"Mitochondria-to-nucleus retrograde signaling drives formation of cytoplasmic chromatin and inflammation in senescence","volume":"34","author":"Vizioli","year":"2020","journal-title":"Genes Dev."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"209","DOI":"10.11138\/ccmbm\/2017.14.1.209","article-title":"Oxidative stress in bone remodeling: Role of antioxidants","volume":"14","author":"Domazetovic","year":"2017","journal-title":"Clin. Cases Miner. Bone Metab."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Agidigbi, T.S., and Kim, C. (2019). Reactive Oxygen Species in Osteoclast Differentiation and Possible Pharmaceutical Targets of ROS-Mediated Osteoclast Diseases. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20143576"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00296-007-0452-0","article-title":"Total oxidative\/anti-oxidative status and relation to bone mineral density in osteoporosis","volume":"28","author":"Altindag","year":"2008","journal-title":"Rheumatol. Int."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"7067984","DOI":"10.1155\/2016\/7067984","article-title":"Oxidative Stress-Related Biomarkers in Postmenopausal Osteoporosis: A Systematic Review and Meta-Analyses","volume":"2016","author":"Zhou","year":"2016","journal-title":"Dis. Markers"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"11643","DOI":"10.1038\/s41598-020-68566-2","article-title":"Mitochondrial dysfunction impairs osteogenesis, increases osteoclast activity, and accelerates age related bone loss","volume":"10","author":"Dobson","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_117","first-page":"276","article-title":"Age-related changes in bone mass in the senescence-accelerated mouse (SAM). SAM-R\/3 and SAM-P\/6 as new murine models for senile osteoporosis","volume":"125","author":"Matsushita","year":"1986","journal-title":"Am. J. Pathol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0197-4580(99)00008-1","article-title":"Senescence-accelerated mouse (SAM): A biogerontological resource in aging research","volume":"20","author":"Takeda","year":"1999","journal-title":"Neuro. Biol. Aging"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s001320170070","article-title":"Cellular senescence: A mechanism of the development of osteoporosis?","volume":"30","author":"Battmann","year":"2001","journal-title":"Orthopade"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/nm.4385","article-title":"Targeting cellular senescence prevents age-related bone loss in mice","volume":"23","author":"Farr","year":"2017","journal-title":"Nat. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"e12923","DOI":"10.1111\/acel.12923","article-title":"Elimination of senescent osteoclast progenitors has no effect on the age-associated loss of bone mass in mice","volume":"18","author":"Kim","year":"2019","journal-title":"Aging Cell"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature05529","article-title":"Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas","volume":"445","author":"Xue","year":"2007","journal-title":"Nature"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/ncb1909","article-title":"Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion","volume":"11","author":"Rodier","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/acel.12597","article-title":"DNA damage and senescence in osteoprogenitors expressing Osx1 may cause their decrease with age","volume":"16","author":"Kim","year":"2017","journal-title":"Aging Cell"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"36396","DOI":"10.1074\/jbc.M111.257071","article-title":"Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype","volume":"286","author":"Coppe","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature11861","article-title":"mTOR is a key modulator of ageing and age-related disease","volume":"493","author":"Johnson","year":"2013","journal-title":"Nature"},{"key":"ref_127","first-page":"107","article-title":"Modulating mTOR in aging and health","volume":"40","author":"Johnson","year":"2015","journal-title":"Interdiscip Top. Gerontol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1038\/s41467-018-04010-4","article-title":"The senescence-associated secretory phenotype is potentiated by feedforward regulatory mechanisms involving Zscan4 and TAK1","volume":"9","author":"Zhang","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1474-9726.2012.00818.x","article-title":"Glucocorticoids suppress selected components of the senescence-associated secretory phenotype","volume":"11","author":"Laberge","year":"2012","journal-title":"Aging Cell"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","article-title":"The senescence-associated secretory phenotype: The dark side of tumor suppression","volume":"5","author":"Coppe","year":"2010","journal-title":"Annu. Rev. Pathol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"C1005","DOI":"10.1152\/ajpcell.00520.2019","article-title":"Irradiation-induced senescence of bone marrow mesenchymal stem cells aggravates osteogenic differentiation dysfunction via paracrine signaling","volume":"318","author":"Bai","year":"2020","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"115220","DOI":"10.1016\/j.bone.2019.115220","article-title":"LPS-induced premature osteocyte senescence: Implications in inflammatory alveolar bone loss and periodontal disease pathogenesis","volume":"132","author":"Rowsey","year":"2020","journal-title":"Bone"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.18632\/aging.102863","article-title":"ATM is a key driver of NF-kappaB-dependent DNA-damage-induced senescence, stem cell dysfunction and aging","volume":"12","author":"Zhao","year":"2020","journal-title":"Aging"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"e34836","DOI":"10.7554\/eLife.34836","article-title":"Boosting ATM activity alleviates aging and extends lifespan in a mouse model of progeria","volume":"7","author":"Qian","year":"2018","journal-title":"Elife"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.molcel.2015.07.011","article-title":"MacroH2A1 and ATM Play Opposing Roles in Paracrine Senescence and the Senescence-Associated Secretory Phenotype","volume":"59","author":"Chen","year":"2015","journal-title":"Mol. Cell"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1158\/0008-5472.CAN-15-1336","article-title":"DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression","volume":"76","author":"Borghesan","year":"2016","journal-title":"Cancer Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.celrep.2018.06.020","article-title":"Regulation of Breast Cancer-Induced Osteoclastogenesis by MacroH2A1.2 Involving EZH2-Mediated H3K27me3","volume":"24","author":"Kim","year":"2018","journal-title":"Cell Rep."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1080\/10715760600915288","article-title":"DNA repair and PARP in aging","volume":"40","author":"Burkle","year":"2006","journal-title":"Free Radic. Res."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1091\/mbc.e05-07-0672","article-title":"PARP1 Is a TRF2-associated poly(ADP-ribose)polymerase and protects eroded telomeres","volume":"17","author":"Gomez","year":"2006","journal-title":"Mol. Biol. Cell"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1093\/nar\/gkn615","article-title":"Rapid regulation of telomere length is mediated by poly(ADP-ribose) polymerase-1","volume":"36","author":"Beneke","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/12680","article-title":"Functions of poly(ADP-ribose) polymerase in controlling telomere length and chromosomal stability","volume":"23","author":"Hande","year":"1999","journal-title":"Nat. Genet."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"28585","DOI":"10.1074\/jbc.M312913200","article-title":"The human Rap1 protein complex and modulation of telomere length","volume":"279","author":"Safari","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"11759","DOI":"10.1073\/pnas.89.24.11759","article-title":"Poly(ADP-ribose) polymerase activity in mononuclear leukocytes of 13 mammalian species correlates with species-specific life span","volume":"89","author":"Grube","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.exger.2007.10.003","article-title":"Effect of zinc on cellular poly(ADP-ribosyl)ation capacity","volume":"43","author":"Kunzmann","year":"2008","journal-title":"Exp. Gerontol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s001090050226","article-title":"Increased poly(ADP-ribose) polymerase activity in lymphoblastoid cell lines from centenarians","volume":"76","author":"Muiras","year":"1998","journal-title":"J. Mol. Med."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/rej.2006.0514","article-title":"Oxidative DNA damage repair and parp 1 and parp 2 expression in Epstein-Barr virus-immortalized B lymphocyte cells from young subjects, old subjects, and centenarians","volume":"10","author":"Chevanne","year":"2007","journal-title":"Rejuvenation Res."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0047-6374(01)00354-2","article-title":"Effect of growth factors on nuclear and mitochondrial ADP-ribosylation processes during astroglial cell development and aging in culture","volume":"123","author":"Cormaci","year":"2002","journal-title":"Mech. Ageing Dev."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0921-8777(00)00016-1","article-title":"Poly(ADP-ribose) polymerase-1: What have we learned from the deficient mouse model?","volume":"460","author":"Shall","year":"2000","journal-title":"Mutat. Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1126\/science.1072221","article-title":"Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor","volume":"297","author":"Yu","year":"2002","journal-title":"Science"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s00018-008-7516-5","article-title":"The roles of poly(ADP-ribose)-metabolizing enzymes in alkylation-induced cell death","volume":"65","author":"Cohausz","year":"2008","journal-title":"Cell Mol. Life Sci."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1007\/s00018-002-8527-2","article-title":"The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders","volume":"59","author":"Hassa","year":"2002","journal-title":"Cell Mol. Life Sci."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","article-title":"Shared principles in NF-kappaB signaling","volume":"132","author":"Hayden","year":"2008","journal-title":"Cell"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"556","DOI":"10.4161\/cc.7.5.5490","article-title":"Reversal of aging by NFkappaB blockade","volume":"7","author":"Adler","year":"2008","journal-title":"Cell Cycle"},{"key":"ref_154","first-page":"219","article-title":"Poly(ADP-ribose) polymerase mediates the suicide response to massive DNA damage: Studies in normal and DNA-repair defective cells","volume":"13","author":"Berger","year":"1983","journal-title":"Princess Takamatsu Symp."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1152\/physiol.00010.2011","article-title":"Calorie restriction: Is AMPK a key sensor and effector?","volume":"26","author":"Canto","year":"2011","journal-title":"Physiology"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s13287-018-0961-7","article-title":"PARP1 inhibitor (PJ34) improves the function of aging-induced endothelial progenitor cells by preserving intracellular NAD(+) levels and increasing SIRT1 activity","volume":"9","author":"Zha","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"7465","DOI":"10.1093\/nar\/gkr454","article-title":"The human DEK oncogene regulates DNA damage response signaling and repair","volume":"39","author":"Kavanaugh","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"7119","DOI":"10.1021\/bi1004365","article-title":"High-affinity interaction of poly(ADP-ribose) and the human DEK oncoprotein depends upon chain length","volume":"49","author":"Fahrer","year":"2010","journal-title":"Biochemistry"},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Yao, H., Sundar, I.K., Gorbunova, V., and Rahman, I. (2013). P21-PARP-1 pathway is involved in cigarette smoke-induced lung DNA damage and cellular senescence. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0080007"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.3802\/jgo.2019.30.e26","article-title":"Olaparib induced senescence under P16 or P53 dependent manner in ovarian cancer","volume":"30","author":"Wang","year":"2019","journal-title":"J. Gynecol. Oncol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/brb3.239","article-title":"PARP1 enhances inflammatory cytokine expression by alteration of promoter chromatin structure in microglia","volume":"4","author":"Ha","year":"2014","journal-title":"Brain. Behav."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3389\/fgene.2018.00417","article-title":"The MacroH2A1.1\u2014PARP1 Axis at the Intersection between Stress Response and Metabolism","volume":"9","author":"Guberovic","year":"2018","journal-title":"Front. Genet."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s42255-019-0121-0","article-title":"A nutritional memory effect counteracts benefits of dietary restriction in old mice","volume":"1","author":"Hahn","year":"2019","journal-title":"Nat. Metab."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cmet.2011.03.004","article-title":"PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation","volume":"13","author":"Bai","year":"2011","journal-title":"Cell Metab."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.mad.2010.05.005","article-title":"Inflammatory and age-related pathologies in mice with ectopic expression of human PARP-1","volume":"131","author":"Mangerich","year":"2010","journal-title":"Mech. Ageing Dev."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Massudi, H., Grant, R., Braidy, N., Guest, J., Farnsworth, B., and Guillemin, G.J. (2012). Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0042357"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"eaat8407","DOI":"10.1126\/science.aat8407","article-title":"Poly(ADP-ribose) drives pathologic alpha-synuclein neurodegeneration in Parkinson\u2019s disease","volume":"362","author":"Kam","year":"2018","journal-title":"Science"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.molcel.2015.04.016","article-title":"Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function","volume":"58","author":"Feng","year":"2015","journal-title":"Mol. Cell"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.celrep.2014.08.036","article-title":"ARTD1\/PARP1 negatively regulates glycolysis by inhibiting hexokinase 1 independent of NAD+ depletion","volume":"8","author":"Fouquerel","year":"2014","journal-title":"Cell Rep."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"10209","DOI":"10.1073\/pnas.1405158111","article-title":"Poly(ADP-ribose) polymerase-dependent energy depletion occurs through inhibition of glycolysis","volume":"111","author":"Andrabi","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1091\/mbc.E18-10-0650","article-title":"NAD+ consumption by PARP1 in response to DNA damage triggers metabolic shift critical for damaged cell survival","volume":"30","author":"Murata","year":"2019","journal-title":"Mol. Biol. Cell"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.cmet.2018.02.011","article-title":"Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence","volume":"27","author":"Rajman","year":"2018","journal-title":"Cell Metab."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cmet.2016.09.017","article-title":"Mammalian Mitochondria and Aging: An Update","volume":"25","author":"Kauppila","year":"2017","journal-title":"Cell Metab."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nrm.2016.14","article-title":"Nuclear DNA damage signalling to mitochondria in ageing","volume":"17","author":"Fang","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1101\/gad.291518.116","article-title":"PARPs and ADP-ribosylation: Recent advances linking molecular functions to biological outcomes","volume":"31","author":"Gupte","year":"2017","journal-title":"Genes Dev."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"21131","DOI":"10.1038\/srep21131","article-title":"ARTD1 regulates osteoclastogenesis and bone homeostasis by dampening NF-kappaB-dependent transcription of IL-1beta","volume":"6","author":"Robaszkiewicz","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.freeradbiomed.2014.07.027","article-title":"The role of p38 signaling and poly(ADP-ribosyl)ation-induced metabolic collapse in the osteogenic differentiation-coupled cell death pathway","volume":"76","author":"Robaszkiewicz","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1016\/j.celrep.2019.05.038","article-title":"Poly(ADP-Ribose) Links the DNA Damage Response and Biomineralization","volume":"27","author":"Muller","year":"2019","journal-title":"Cell Rep."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1161\/ATVBAHA.120.313792","article-title":"DNA Damage Response: A Molecular Lynchpin in the Pathobiology of Arteriosclerotic Calcification","volume":"40","author":"Duer","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Zengin, A., Jarjou, L.M., Janha, R.E., Prentice, A., Cooper, C., Ebeling, P.R., and Ward, K.A. (2020). Sex-Specific Associations Between Cardiac Workload, Peripheral Vascular Calcification, and Bone Mineral Density: The Gambian Bone and Muscle Aging Study. J. Bone Miner. Res.","DOI":"10.1017\/S002966512100032X"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bbrc.2012.03.064","article-title":"Increased transcript level of poly(ADP-ribose) polymerase (PARP-1) in human tricuspid compared with bicuspid aortic valves correlates with the stenosis severity","volume":"420","author":"Nagy","year":"2012","journal-title":"BioChem. Biophys Res. Commun."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/s41467-019-09174-1","article-title":"Poly(ADP-ribose) polymerase 1 accelerates vascular calcification by upregulating Runx2","volume":"10","author":"Wang","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_183","unstructured":"(2003). Forteo approved for osteoporosis treatment. FDA Consum., 37, 4."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3949\/ccjm.70.7.585","article-title":"Recombinant human PTH 1-34 (Forteo): An anabolic drug for osteoporosis","volume":"70","author":"Deal","year":"2003","journal-title":"Cleve Clin. J. Med."},{"key":"ref_185","first-page":"423","article-title":"Forteo (teriparatide): First approved medication to rebuild bone","volume":"56","author":"Hutton","year":"2003","journal-title":"S. D. J. Med."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/01926230490462138","article-title":"Bone neoplasms in F344 rats given teriparatide [rhPTH(1-34)] are dependent on duration of treatment and dose","volume":"32","author":"Vahle","year":"2004","journal-title":"Toxicol. Pathol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1002\/pds.5103","article-title":"Assessing the incidence of osteosarcoma among teriparatide users based on Medicare Part D and US State Cancer Registry Data","volume":"29","author":"Gilsenan","year":"2020","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.bone.2009.05.006","article-title":"Parathyroid hormone suppresses osteoblast apoptosis by augmenting DNA repair","volume":"45","author":"Schnoke","year":"2009","journal-title":"Bone"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"e12755","DOI":"10.1111\/cpr.12755","article-title":"Parathyroid hormone ameliorates temporomandibular joint osteoarthritic-like changes related to age","volume":"53","author":"Cui","year":"2020","journal-title":"Cell Prolif."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1002\/jbmr.1718","article-title":"High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: The Center of Excellence for Osteoporosis Research Study","volume":"27","author":"Ardawi","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1002\/jbmr.479","article-title":"Determinants of serum sclerostin in healthy pre- and postmenopausal women","volume":"26","author":"Ardawi","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"ref_192","first-page":"866","article-title":"Serum sclerostin levels decline in post-menopausal women with osteoporosis following treatment with intermittent parathyroid hormone","volume":"35","author":"Piemonte","year":"2012","journal-title":"J. Endocrinol. Investig."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jbmr.217","article-title":"Relation of age, gender, and bone mass to circulating sclerostin levels in women and men","volume":"26","author":"Modder","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00774-013-0451-z","article-title":"Serum sclerostin levels in healthy men over 50 years of age","volume":"31","author":"Bhattoa","year":"2013","journal-title":"J. Bone Miner. Metab."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2013.10.019","article-title":"Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans","volume":"59","author":"Roforth","year":"2014","journal-title":"Bone"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1159\/000358303","article-title":"Serum levels of sclerostin and dickkopf-1: Effects of age, gender and fracture status","volume":"60","author":"Dovjak","year":"2014","journal-title":"Gerontology"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/jbmr.2342","article-title":"Methylation of bone SOST, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women","volume":"30","author":"Reppe","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Gombos, G.C., Bajsz, V., Pek, E., Schmidt, B., Sio, E., Molics, B., and Betlehem, J. (2016). Direct effects of physical training on markers of bone metabolism and serum sclerostin concentrations in older adults with low bone mass. BMC Musculoskelet Disord., 17.","DOI":"10.1186\/s12891-016-1109-5"},{"key":"ref_199","first-page":"142","article-title":"Effects of physical activity on sclerostin concentrations","volume":"69","author":"Janik","year":"2018","journal-title":"Endokrynol. Pol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/jcb.24537","article-title":"Sclerostin is expressed in osteoclasts from aged mice and reduces osteoclast-mediated stimulation of mineralization","volume":"114","author":"Ota","year":"2013","journal-title":"J. Cell BioChem."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","article-title":"Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)","volume":"10","author":"Balemans","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1086\/302416","article-title":"Localization of the gene for sclerosteosis to the van Buchem disease-gene region on chromosome 17q12-q21","volume":"64","author":"Balemans","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.080216","article-title":"Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength","volume":"23","author":"Li","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1359\/jbmr.081206","article-title":"Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis","volume":"24","author":"Li","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density","volume":"370","author":"McClung","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/S0140-6736(17)31613-6","article-title":"Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: A randomised, open-label, phase 3 trial","volume":"390","author":"Langdahl","year":"2017","journal-title":"Lancet"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.yrtph.2016.08.010","article-title":"Carcinogenicity risk assessment of romosozumab: A review of scientific weight-of-evidence and findings in a rat lifetime pharmacology study","volume":"81","author":"Chouinard","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/jbmr.3452","article-title":"Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group Study","volume":"33","author":"McClung","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1007\/s00198-020-05502-0","article-title":"A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab","volume":"31","author":"McClung","year":"2020","journal-title":"Osteoporos. Int."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1359\/jbmr.1999.14.5.722","article-title":"The role of geranylgeranylation in bone resorption and its suppression by bisphosphonates in fetal bone explants in vitro: A clue to the mechanism of action of nitrogen-containing bisphosphonates","volume":"14","author":"Lowik","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1177\/154405910708601102","article-title":"Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates","volume":"86","author":"Kimmel","year":"2007","journal-title":"J. Dent. Res."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41467-017-00314-z","article-title":"Identification of HSP90 inhibitors as a novel class of senolytics","volume":"8","author":"Ling","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/acel.12344","article-title":"The Achilles\u2019 heel of senescent cells: From transcriptome to senolytic drugs","volume":"14","author":"Zhu","year":"2015","journal-title":"Aging Cell"},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"Sun, K., Sun, Y., Li, H., Han, D., Bai, Y., Zhao, R., and Guo, Z. (2020). Anti-Ageing Effect of Physalis alkekengi Ethyl Acetate Layer on a d-galactose-Induced Mouse Model through the Reduction of Cellular Senescence and Oxidative Stress. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21051836"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ebiom.2018.09.015","article-title":"Fisetin is a senotherapeutic that extends health and lifespan","volume":"36","author":"Yousefzadeh","year":"2018","journal-title":"EBioMedicine"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"955","DOI":"10.18632\/aging.101202","article-title":"New agents that target senescent cells: The flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463","volume":"9","author":"Zhu","year":"2017","journal-title":"Aging"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nm.4010","article-title":"Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice","volume":"22","author":"Chang","year":"2016","journal-title":"Nat. Med."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.18632\/aging.101100","article-title":"Discovery of piperlongumine as a potential novel lead for the development of senolytic agents","volume":"8","author":"Wang","year":"2016","journal-title":"Aging"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"e54693","DOI":"10.7554\/eLife.54693","article-title":"Senotherapeutic drugs for human intervertebral disc degeneration and low back pain","volume":"9","author":"Cherif","year":"2020","journal-title":"Elife"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1101\/gad.332643.119","article-title":"The senotherapeutic drug ABT-737 disrupts aberrant p21 expression to restore liver regeneration in adult mice","volume":"34","author":"Ritschka","year":"2020","journal-title":"Genes Dev."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1038\/s41467-020-16347-w","article-title":"The CD153 vaccine is a senotherapeutic option for preventing the accumulation of senescent T cells in mice","volume":"11","author":"Yoshida","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.bbrc.2005.07.014","article-title":"Aspirin reduces endothelial cell senescence","volume":"334","author":"Tager","year":"2005","journal-title":"BioChem. Biophys. Res. Commun."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1096\/fba.2019-00041","article-title":"Aspirin ameliorates the long-term adverse effects of doxorubicin through suppression of cellular senescence","volume":"1","author":"Feng","year":"2019","journal-title":"FASEB BioAdv."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1146\/annurev-pharmtox-050120-105018","article-title":"Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span","volume":"61","author":"Robbins","year":"2021","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1038\/s41598-018-20000-4","article-title":"Small-molecule MDM2 antagonists attenuate the senescence-associated secretory phenotype","volume":"8","author":"Wiley","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"e93203","DOI":"10.1172\/jci.insight.93203","article-title":"mTOR pathway activation drives lung cell senescence and emphysema","volume":"3","author":"Houssaini","year":"2018","journal-title":"JCI Insight"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/acel.12587","article-title":"Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism","volume":"16","author":"Wang","year":"2017","journal-title":"Aging Cell"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"e2408","DOI":"10.1038\/cddis.2016.249","article-title":"Loss of Rictor with aging in osteoblasts promotes age-related bone loss","volume":"7","author":"Lai","year":"2016","journal-title":"Cell Death Dis."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1210\/en.2016-1739","article-title":"Sirtuin-3 Promotes Adipogenesis, Osteoclastogenesis, and Bone Loss in Aging Male Mice","volume":"158","author":"Ho","year":"2017","journal-title":"Endocrinology"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11357-017-9994-6","article-title":"Rapamycin treatment attenuates age-associated periodontitis in mice","volume":"39","author":"An","year":"2017","journal-title":"Geroscience"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"e13163","DOI":"10.1111\/acel.13163","article-title":"Poly (ADP-ribose) polymerase 1 inhibition prevents neurodegeneration and promotes alpha-synuclein degradation via transcription factor EB-dependent autophagy in mutant alpha-synucleinA53T model of Parkinson\u2019s disease","volume":"19","author":"Mao","year":"2020","journal-title":"Aging Cell"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"820","DOI":"10.18632\/aging.100696","article-title":"Dysregulation of SIRT-1 in aging mice increases skeletal muscle fatigue by a PARP-1-dependent mechanism","volume":"6","author":"Mohamed","year":"2014","journal-title":"Aging"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3389\/fcell.2020.00354","article-title":"The Senolytic Drug Navitoclax (ABT-263) Causes Trabecular Bone Loss and Impaired Osteoprogenitor Function in Aged Mice","volume":"8","author":"Sharma","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"810563","DOI":"10.1155\/2012\/810563","article-title":"Fisetin Inhibits Osteoclast Differentiation via Downregulation of p38 and c-Fos-NFATc1 Signaling Pathways","volume":"2012","author":"Choi","year":"2012","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"ref_235","doi-asserted-by":"crossref","unstructured":"Leotoing, L., Wauquier, F., Guicheux, J., Miot-Noirault, E., Wittrant, Y., and Coxam, V. (2013). The polyphenol fisetin protects bone by repressing NF-kappaB and MKP-1-dependent signaling pathways in osteoclasts. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0068388"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/7\/3553\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:55:35Z","timestamp":1760363735000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/7\/3553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,29]]},"references-count":235,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["ijms22073553"],"URL":"https:\/\/doi.org\/10.3390\/ijms22073553","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,29]]}}}